Navigation Links
Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
Date:1/31/2008

tual results to differ materially from those in the forward-

looking statements. Such risks and uncertainties include, among others,

the availability of funds and resources to pursue research and

development projects, the efficacy of REOLYSIN(R) as a cancer treatment,

the tolerability of REOLYSIN(R) outside a controlled test, the success

and timely completion of clinical studies and trials, the Company's

ability to successfully commercialize REOLYSIN(R), uncertainties related

to the research and development of pharmaceuticals and uncertainties

related to the regulatory process. Investors should consult the Company's

quarterly and annual filings with the Canadian and U.S. securities

commissions for additional information on risks and uncertainties

relating to the forward-looking statements. Investors are cautioned

against placing undue reliance on forward-looking statements. The Company

does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
3. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
4. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
5. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
6. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
7. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
10. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
11. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... The global market for biotechnology is ... to a new study by Grand View Research, Inc. ... effective vaccines and drugs in an attempt to improve ... expected to drive market demand over the next six ... via the use of genetically engineered seeds is expected ...
(Date:7/26/2014)... NY (PRWEB) July 26, 2014 ... provides key market data on the Canada Endoscopy ... millions of US dollars, volume (in units) and ... - High-End Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization ... Full Report at http://www.marketresearchreports.biz/analysis/213254 . , The ...
(Date:7/25/2014)... DUBLIN , July 25, 2014 ... of the "Global Metabolomics Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Metabolomics or Metabonomics ... metabolites. Metabolomics has become a new experimental technique ... and the environmental sciences. Metabolites are small molecules ...
(Date:7/25/2014)... 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... today announced financial results for the period ended June ... , Reported cash and cash equivalents totaling $37.4 ... December 31, 2013.  , Reported a net loss ...
Breaking Biology Technology:Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6
... 2011  Kensey Nash Corporation (Nasdaq: KNSY ) ... Corporation (Nasdaq: SPNC ) that they reached ... endovascular product lines purchased from Kensey Nash in May ... milestone payable to Kensey Nash.  As previously disclosed, the ...
... 12, 2011  Fox Insurance Company, a Medicare Part D ... judgment in the arbitration between the company and ProCare, ... million, following a suit against ProCare based on Fox,s ... Nathan M. Barotz, chairman of Fox Insurance Company ...
... SAN DIEGO, Dec. 11, 2011 Research assessing the safety ... cell disease (SCD) and the use of pre-operative transfusions for ... will be presented today at the 53rd Annual Meeting of ... to 100,000 Americans are affected each year by SCD, a ...
Cached Biology Technology:Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager 2Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 2Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 3Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 4Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 5Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 6Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 7
(Date:7/28/2014)... at Yale School of Medicine have pinpointed a mechanism in ... levels in the blood, linking it to both type 1 ... July 28 issue of Proceedings of the National Academies ... endopeptidase enzyme located in a part of the hypothalamus ... steps in motion that control glucose levels in the blood," ...
(Date:7/28/2014)... new study suggest two ways to effectively address the problem ... obese women, compared to women of a normal body mass ... say, but as the population has increased in weight, concern ... women. Studies have consistently found that obesity has a negative ... turn affect how well the pill prevents pregnancy. ...
(Date:7/28/2014)... NEW YORK CITY (July 28, 2014)The Brain & ... its annual Klerman and Freedman Prizes, recognizing exceptional ... have been supported by NARSAD Young Investigator Grants. ... innovative ideas in neurobiological and psychosocial research for ... mental illnesses that affect one in four people. ...
Breaking Biology News(10 mins):Glucose 'control switch' in the brain key to both types of diabetes 2Strategies identified to improve oral contraceptive success with obese women 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4
... dietary supplements should not be taken during radiation ... increase the radiosensitivity of normal prostate cell lines, ... study in the March issue of the ... journal of the American Society for Radiation Oncology ...
... is available in Spanish . Farmers ... to buy seeds for crops, especially those with sought after ... seeds themselves because the very act of sexual reproduction erases ... farmers must purchase new supplies of specially-produced seeds. This ...
... 2010 During the school day, children eat roughly ... Besides lunch, breakfast and snacks may be served, providing ... food. With economical constraints interfering with schools to ... vegetables, a study in the March/April issue of the ...
Cached Biology News:Dietary supplements discouraged for prostate cancer patients 2Asexual plant reproduction may seed new approach for agriculture 2Asexual plant reproduction may seed new approach for agriculture 3Asexual plant reproduction may seed new approach for agriculture 4Farm-to-school programs motivate school food service professionals 2Farm-to-school programs motivate school food service professionals 3
... that it uses a deep-UV deuterium bulb, which ... with a shutter (controlled via a TTL signal ... DH-2000 Deuterium Tungsten Halogen Light Source combines ... light sources in a single optical path. The ...
... The IITC Model 20-NW cuff pump is a ... pressure testing. This cuff pump replaces manual inflation ... blood pressure test systems for mouse and rat; ... The IITC Model 20-NW cuff pump has adjustable ...
... These handy dispensers save space ... hats, and other garb. They are ... small parts used in labs, processing ... static charges and the particles they ...
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
Biology Products: